Durect competitorsClear all
Durect's top competitors include Array BioPharma, Amicus Therapeutics, Clinigen Group and Recro Gainesville.
| Save Comparison |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Clinigen Group A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time |  Recro Gainesville Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |
Founding Date | Founding Date N/A | Founding Date 1998 | Founding Date 2002 | Founding Date 2010 | Founding Date 2006 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cupertino, US HQ | Locations Boulder, US HQ Cambridge, US Chicago, US Detroit, US Houston, US Miami, US Morrisville, US see more | Locations Cranbury Township, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin 15, IE Milano, IT see more | Locations Burton upon Trent, GB HQ Warriewood, AU Chuo City, JP Singapore, SG Pretoria, ZA Hobson, GB London, GB see more | Locations Malvern, US HQ Gainesville, US Gainesville, US |
Employees | Employees 902% increase | Employees 29843% increase | Employees 58415% increase | Employees 1,13342% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) 467.3 m | Valuation ($) N/A | Valuation ($) 5.5 b | Valuation ($) 1.3 b | Valuation ($) 76.8 m |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.7 k | Twitter followers 1.4 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.6 | Average likes per tweet (last 30 days) 1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 197124 | Alexa Website Rank N/A | Alexa Website Rank 304877 | Alexa Website Rank 645582 | Alexa Website Rank 186566 |
Employee Rating | Employee Rating 3.5 | Employee Rating 3.5 | Employee Rating 3 | Employee Rating 2.8 | Employee Rating 4.1 |
Financial | |||||
Revenue (est.) | Revenue (est.) $29.6m (FY, 2019) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $182.2m (FY, 2019) | Revenue (est.) £456.9m (FY, 2019) | Revenue (est.) $99.2m (FY, 2019) |
Cost of goods | Cost of goods $4.1m (FY, 2019) | Cost of goods $59.4m (FY, 2018) | Cost of goods $22m (FY, 2019) | Cost of goods £274.6m (FY, 2019) | Cost of goods $51m (FY, 2019) |
Gross profit | Gross profit $25.4m (FY, 2019) | Gross profit $114.4m (FY, 2018) | Gross profit $160.3m (FY, 2019) | Gross profit £182.3m (FY, 2019) | Gross profit $48.2m (FY, 2019) |
Net income | Net income ($20.6m) (FY, 2019) | Net income ($147.7m) (FY, 2018) | Net income ($356.4m) (FY, 2019) | Net income £5.2m (FY, 2019) | Net income ($18.6m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 88m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View companyAmicus Therapeutics
HQ
Cranbury Township, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyClinigen Group
HQ
Burton upon Trent, GB
Employees
1,133↑ 42% increase
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
View companyRecro Gainesville
HQ
Malvern, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company